Phosphatidylinositol 3-kinase-AKT-mammalian target of rapamycin pathway is essential for neuroendocrine differentiation of prostate cancer (Q40200388)
scientific article published on 4 December 2006
Language:
Current Data About Phosphatidylinositol 3-kinase-AKT-mammalian target of rapamycin pathway is essential for neuroendocrine differentiation of prostate cancer
(P31) (Q13442814)
(P248)
(P698) 17148458
(P813) Monday, September 18, 2017

(P304) 3571-3583
(P248)
(P698) 17148458
(P813) Monday, September 18, 2017

(P407) (Q1860)

(P433) 6
(P248)
(P698) 17148458
(P813) Monday, September 18, 2017

(P478) 282
(P248)
(P698) 17148458
(P813) Monday, September 18, 2017

(P577) Monday, December 4, 2006
(P248)
(P698) 17148458
(P813) Monday, September 18, 2017

(P921) (Q32089)
(P887)

(P1104) 13
(P887)

(P1433) (Q867727)
(P248)
(P698) 17148458
(P813) Monday, September 18, 2017

(P1476) "Phosphatidylinositol 3-kinase-AKT-mammalian target of rapamycin pathway is essential for neuroendocrine differentiation of prostate cancer" (language: en)
(P248)
(P698) 17148458
(P813) Monday, September 18, 2017

(P2093) Chengyu Wu
(P1545) 1
(P248)
(P698) 17148458
(P813) Monday, September 18, 2017

Jiaoti Huang
(P1545) 2
(P248)
(P698) 17148458
(P813) Monday, September 18, 2017

other details
description scientific article published on 4 December 2006

External Links
(P356) 10.1074/JBC.M608487200
(P698) 17148458